This federal contract award, identified as SPE2DB20D1102|SPE2DB25FC5WK, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,084.38, is for the delivery of M-M-R II VACCINE VIALS.
The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of December 30, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002.
In addition to this specific contract, Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/28/25, 9:49 AM